Sun Pharma plans Rs.10,000 crore bond sale to refinance Organon acquisition loan: Report

New Delhi, Sept. 29 -- India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt sale to partly fund a bridge loan it took to acquire US healthcare firm Organon & Co., three sources said on Tuesday.Bridge loans are typically sh…